A prospective randomized controlled trial for hepatectomy combined with radiofrequency ablation and hepatectomy alone in the treatment of multiple liver cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000028779

Enrollment

Unknown

Registered

2020-01-03

Start date

2020-03-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic carcinoma

Interventions

Two groups:HR versus HR+RFA

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. HCC is diagnosed and treated for the first time; 2. Male or female patients aged 18-75 years; 3. There are 2-3 multiple liver cancer, one of which is more than 3cm (main tumor), the others are less than 3cm (minor tumor); 4. No extrahepatic metastasis or vascular invasion was found; 5. Liver function Pugh child class A; 6. Icg-r15 50x10^9/L; 8. No refractory ascites; 9. Patients must be suitable for HR and HR combined RFA at the same time.

Exclusion criteria

Exclusion criteria: 1. Those who refuse to sign informed consent; 2. Patients can't perform HR and HR combined RFA at the same time; 3. Patients require liver transplantation.

Design outcomes

Primary

Measure	Time frame
prognosis;	—

Countries

China

Contacts

Public ContactLi Jiang

School of Clinical Medicine, West China Hospital, Sichuan University

jl339@126.com+86 18980606338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026